Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice. [electronic resource]
Producer: 20210107Description: 172891 p. digitalISSN:- 1873-5177
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- adverse effects
- Animals
- Antiparkinson Agents -- administration & dosage
- Blood-Brain Barrier -- drug effects
- Cell Death -- drug effects
- Cognitive Dysfunction -- drug therapy
- Disease Models, Animal
- Dopaminergic Neurons -- drug effects
- Fatty Acid Binding Protein 3 -- metabolism
- Levodopa -- administration & dosage
- Ligands
- Male
- Mice
- Mice, Inbred C57BL
- Motor Activity -- drug effects
- Neuroprotective Agents -- administration & dosage
- Parkinson Disease -- drug therapy
- Protein Aggregation, Pathological -- drug therapy
- alpha-Synuclein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.